NPs Basic Information
|
Name |
Engyodontiumone I
|
| Molecular Formula | C15H20O4 | |
| IUPAC Name* |
3-hydroxy-4-[(E)-6-hydroxy-6-methylhept-2-en-2-yl]benzoic acid
|
|
| SMILES |
C/C(=C\CCC(C)(C)O)/C1=C(C=C(C=C1)C(=O)O)O
|
|
| InChI |
InChI=1S/C15H20O4/c1-10(5-4-8-15(2,3)19)12-7-6-11(14(17)18)9-13(12)16/h5-7,9,16,19H,4,8H2,1-3H3,(H,17,18)/b10-5+
|
|
| InChIKey |
YKESKAIEXRBSCH-BJMVGYQFSA-N
|
|
| Synonyms |
Engyodontiumone I
|
|
| CAS | NA | |
| PubChem CID | 139586970 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 264.32 | ALogp: | 2.9 |
| HBD: | 3 | HBA: | 4 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 77.8 | Aromatic Rings: | 1 |
| Heavy Atoms: | 19 | QED Weighted: | 0.755 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.708 | MDCK Permeability: | 0.00001810 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.005 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.047 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.075 | Plasma Protein Binding (PPB): | 66.77% |
| Volume Distribution (VD): | 0.333 | Fu: | 41.78% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.166 | CYP1A2-substrate: | 0.471 |
| CYP2C19-inhibitor: | 0.05 | CYP2C19-substrate: | 0.05 |
| CYP2C9-inhibitor: | 0.326 | CYP2C9-substrate: | 0.235 |
| CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.097 |
| CYP3A4-inhibitor: | 0.067 | CYP3A4-substrate: | 0.087 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 2.84 | Half-life (T1/2): | 0.902 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.53 |
| Drug-inuced Liver Injury (DILI): | 0.956 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.138 | Maximum Recommended Daily Dose: | 0.025 |
| Skin Sensitization: | 0.068 | Carcinogencity: | 0.025 |
| Eye Corrosion: | 0.008 | Eye Irritation: | 0.749 |
| Respiratory Toxicity: | 0.027 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004195 |  |
0.656 | D01WJL |  |
0.362 | ||
| ENC004196 |  |
0.656 | D0BA6T |  |
0.328 | ||
| ENC005625 |  |
0.639 | D0C4YC |  |
0.317 | ||
| ENC002565 |  |
0.545 | D0P7JZ |  |
0.314 | ||
| ENC002383 |  |
0.545 | D05VIX |  |
0.307 | ||
| ENC002688 |  |
0.515 | D02ZJI |  |
0.301 | ||
| ENC002564 |  |
0.493 | D0K5CB |  |
0.301 | ||
| ENC003302 |  |
0.478 | D0Y6KO |  |
0.297 | ||
| ENC001090 |  |
0.475 | D0S2BT |  |
0.290 | ||
| ENC004987 |  |
0.475 | D0V9EN |  |
0.288 | ||